Heart attack drug dilemma: shorter may be safer
NCT ID NCT03252249
First seen Feb 01, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study looked at how long people who had a heart attack should take two blood-thinning medicines (aspirin plus a second drug). Over 5,000 patients were randomly assigned to shorter or longer treatment. The goal was to find the best balance between preventing another heart attack and avoiding dangerous bleeding. Results help doctors decide the safest treatment length.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Edinburgh Royal Infirmary
Edinburgh, United Kingdom
Conditions
Explore the condition pages connected to this study.